What is Avalo Therapeutics's current ratio?

Avalo Therapeutics (AVTX) reported current ratio of 7.7× in Q1 2026.

How has Avalo Therapeutics's current ratio changed year-over-year?

Avalo Therapeutics's current ratio decreased by 66.1% year-over-year, from 22.6× to 7.7×.

What is the long-term trend for Avalo Therapeutics's current ratio?

Over 5 years (2020 to 2025), Avalo Therapeutics's current ratio has grown at a 36.6% compound annual growth rate (CAGR), from 1.7× to 8.1×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Avalo Therapeutics AVTX Current ratio

Current ratio at other companies

Eli LillyLLY

1.5×+0.1×

AbbVieABBV

0.8×0.0×

XencorXNCR

6.6×+0.7×

AbCellera Biologics Inc.ABCL

14.1×+3.9×

AnaptysBio, Inc.ANAB

7.6×-0.7×

Absci CorporationABSI

6.6×+0.9×

Other financials

Income statement

See full

Revenue$59.0K-69.3%

Gross profit$963.0K+8,855%

Operating income-$20.9M-42.5%

Net income-$19.6M-49.3%

EPS (diluted)-$0.98+21.6%

Balance sheet

See full

Cash & equivalents$25.3M-79.8%

Total debt$328.0K-59.1%

Total equity$68.3M-44.3%

Total assets$99.9M-27.9%

Cash flow

See full

Operating cash flow-$17.7M-87.1%

CapEx-—

Free cash flow-$15.0M-444%

Valuation

See full

Market cap$954.59M+1,800%

Enterprise value$929.6M-1,353%

P/S1,909.2×+1,868×

Profitability

See full

Gross margin182%+176pp

Operating margin-15,536.1%-17,275pp

Net margin-7,965.8%-10,750pp

FCF margin-11,123.8%-13,374pp

Returns & leverage

See full

Return on equity-88.8%—

Debt / equity0×0.0×

Where this comes from

Calculated from Avalo Therapeutics’s reported figures.

total current assets/total current liabilities=7.7×

Based on the most recent quarter.

The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avalo Therapeutics's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Avalo Therapeutics's current ratio?: Avalo Therapeutics (AVTX) reported current ratio of 7.7× in Q1 2026.
How has Avalo Therapeutics's current ratio changed year-over-year?: Avalo Therapeutics's current ratio decreased by 66.1% year-over-year, from 22.6× to 7.7×.
What is the long-term trend for Avalo Therapeutics's current ratio?: Over 5 years (2020 to 2025), Avalo Therapeutics's current ratio has grown at a 36.6% compound annual growth rate (CAGR), from 1.7× to 8.1×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.